Advertisement

Surveillance and management of ventriculitis following neurosurgery

  • H. Humphreys
    Correspondence
    Corresponding author. Address: Department of Clinical Microbiology, RCSI Education and Research Centre, Beaumont Hospital, PO Box 9063, Dublin 9, Ireland. Tel.: +3531 8093708/3710; fax: +3531 8092871.
    Affiliations
    Department of Clinical Microbiology, The Royal College of Surgeons in Ireland, Dublin, Ireland

    Department of Microbiology, Beaumont Hospital, Dublin, Ireland
    Search for articles by this author
  • P.J. Jenks
    Affiliations
    Department of Microbiology, Plymouth Hospitals NHS Trust, Plymouth, UK
    Search for articles by this author
Published:January 28, 2015DOI:https://doi.org/10.1016/j.jhin.2014.12.019

      Summary

      Ventriculitis is an important complication following neurosurgery and is often associated with the use of an external ventricular drain (EVD). The incidence varies from <5% to 20%, partly due to variations in the definitions used for diagnosis. Staphylococci are the most important causes but the isolation of coagulase-negative staphylococci from a cerebrospinal fluid (CSF) sample needs to be interpreted with caution as it may represent contamination. Risk factors for ventriculitis include advanced age, the duration of EVD placement, the number of manipulations and the presence of intraventricular haemorrhage. Prevention strategies increasingly focus on the implementation of a care bundle that includes aseptic technique at the time of insertion and during any manipulations, skin preparation, prophylactic antibiotics, and appropriate dressings at the site of the EVD. The use of EVDs impregnated with antimicrobial agents is increasing but, whereas some studies show that these are effective, it is not clear whether they provide added benefit when there is compliance with other measures. Antimicrobial treatment is challenging as many widely used agents do not penetrate into the CSF and causative bacteria are increasingly multidrug resistant. Often a combination of high-dose intravenous and intraventricular agents is required, especially for Gram-negative infections. Large trials in this area are challenging to conduct; therefore, to better inform preventive strategies and to optimize management of this important condition, ongoing national surveillance and pooling of data on treatment approaches and outcomes are needed.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hospital Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Smyth E.T.
        • McIllvenny G.
        • Enstone J.E.
        • et al.
        Four country healthcare associated infection prevalence survey 2006: overview of the results.
        J Hosp Infect. 2008; 69: 230-248
        • Magill S.S.
        • Edwards J.R.
        • Bamberg W.
        • et al.
        Multistate point-prevalence survey of health-care-associated infections.
        N Engl J Med. 2014; 370: 1198-1208
        • Orsi G.B.
        • Scorzolini L.
        • Franchi C.
        • Mondillo V.
        • Rosa G.
        • Venditti M.
        Hospital-acquired infection surveillance in a neurosurgical intensive care unit.
        J Hosp Infect. 2006; 64: 23-29
        • Dettenkofer M.
        • Ebner W.
        • Els T.
        • et al.
        Surveillance of nosocomial infections in a neurology intensive care unit.
        J Neurol. 2001; 248: 959-964
        • Williamson R.A.
        • Phillips-Bute B.G.
        • McDonagh D.L.
        • et al.
        Predictors of extraventricular drain-associated bacterial ventriculitis.
        J Crit Care. 2014; 29: 77-82
        • Arabi Y.
        • Memish Z.A.
        • Balkhy H.H.
        • et al.
        Ventriculostomy-associated infections: incidence and risk factors.
        Am J Infect Control. 2004; 33: 137-142
        • Beer R.
        • Lackner P.
        • Pfausler B.
        • Schmutzhard E.
        Nosocomial ventriculitis and meningitis in neurocritical care patients.
        J Neurol. 2008; 255: 1617-1624
        • Sonabend A.M.
        • Korenfeld Y.
        • Crisman C.
        • Badjatia N.
        • Mayer S.A.
        • Connolly E.S.
        Prevention of ventriculostomy-related infections with prophylactic antibiotics and antibiotic-coated external ventricular drains: a systematic review.
        Neurosurgery. 2011; 68: 996-1005
        • Walti L.N.
        • Conen A.
        • Coward J.
        • Jost G.F.
        • Trampuz A.
        Characteristics of infections associated with external ventricular drains of cerebrospinal fluid.
        J Infect. 2013; 66: 424-431
        • Scheithauer S.
        • Bürgel U.
        • Ryang Y.-M.
        • et al.
        Prospective surveillance of drain associated meningitis/ventriculitis in a neurosurgery and neurological intensive care unit.
        J Neurol Neurosurg Psychiatry. 2009; 80: 1381-1385
        • van Mourik M.S.M.
        • Moons K.G.M.
        • van Solinge W.W.
        • et al.
        Automated detection of healthcare associated infections: external validation and updating of a model for surveillance of drain-related meningitis.
        PLOS One. 2012; 7: 1-7
        • Huang C.-R.
        • Lu C.-H.
        • Wu J.-J.
        • et al.
        Coagulase-negative staphylococcal meningitis in adults: clinical characteristics and therapeutic outcomes.
        Infect. 2005; 33: 56-60
        • Stevens N.T.
        • Tharmabala M.
        • Dillane T.
        • Greene C.M.
        • O'Gara J.P.
        • Humphreys H.
        Biofilm and the role of the ica operon and aap in Staphylococcus epidermidis isolates causing neurosurgical meningitis.
        Clin Microbiol Infect. 2008; 14: 719-722
        • Stevens N.T.
        • Greene C.M.
        • O'Gara J.P.
        • et al.
        Ventriculoperitoneal shunt-related infections caused by Staphylococcus epidermidis: pathogenesis and implications for treatment.
        Br J Neurosurg. 2012; 26: 792-797
        • Enoch D.A.
        • Summers C.
        • Brown N.M.
        • et al.
        Investigation and management of an outbreak of multidrug-carbapenem-resistant Acinetobacter baumannii in Cambridge, UK.
        J Hosp Infect. 2008; 70: 109-118
        • Korinek A.-M.
        • Reina M.
        • Boch A.L.
        • Rivera A.O.
        • Puybasset L.
        Prevention of external ventricular drain-related ventriculitis.
        Acta Neurochir. 2005; 147: 39-46
        • Honda H.
        • Jones J.C.
        • Craighead M.C.
        • Diringer M.N.
        • Dacey R.G.
        • Warren D.K.
        Reducing the incidence of intraventricular catheter-related ventriculitis in the neurology‒neurosurgical intensive care unit at a tertiary care centre in St Louis, Missouri: an 8-year follow-up study.
        Infect Control Hosp Epidemiol. 2010; 31: 1078-1081
        • Levernstein-van Hall M.A.
        • Hopmans T.E.M.
        • van der Sprenkel J.W.B.
        • et al.
        A bundle approach to reduce the incidence of external ventricular and lumbar drain-related infections.
        J Neurosurg. 2010; 112: 345-353
        • Flint A.C.
        • Rao V.A.
        • Renda N.C.
        • Faigeles B.S.
        • Lasman T.E.
        • Sheridan W.
        A simple protocol to prevent external ventricular drain infections.
        Neurosurgery. 2013; 72: 993-999
        • Williams T.A.
        • Leslie G.D.
        • Dobb G.J.
        • Roberts B.
        • van Herden P.V.
        Decrease in proven ventriculitis by reducing the frequency of cerebrospinal fluid sampling from extraventricular drains.
        J Neurosurg. 2011; 115: 1040-1046
        • Infection in Neurosurgery Working Party of the British Society for Antimicrobial Chemotherapy
        Antimicrobial prophylaxis in neurosurgery and after head injury.
        Lancet. 1994; 344: 1547-1550
        • Pople I.
        • Poon W.
        • Assaker R.
        • et al.
        Comparison of infection rates with the use of antibiotic-impregnated vs standard extraventricular drainage devices: a prospective, randomised controlled trial.
        Neurosurgery. 2012; 71: 6-12
        • Abla A.A.
        • Zabramski J.M.
        • Jahnke H.K.
        • Fusco D.
        • Nakaji P.
        Comparison of two antibiotic-impregnated ventricular catheters: a prospective sequential series trial.
        Neurosurgery. 2011; 68: 437-442
        • Keong N.C.H.
        • Bulters D.O.
        • Richards H.K.
        • et al.
        The SILVER (silver impregnated line versus EVD randomised trial): a double-blind, prospective, randomised controlled trial of an intervention to reduce the rate of external ventricular drain infection.
        Neurosurgery. 2012; 71: 394-404
        • Infection in Neurosurgery Working Party of the British Society for Antimicrobial Chemotherapy
        The management of neurosurgical patients with postoperative bacterial or aseptic meningitis or external ventricular drain-associated ventriculitis.
        Br J Neurosurg. 2000; 14: 7-12
        • Ng K.
        • Mabasa V.H.
        • Chow I.
        • Ensom M.H.H.
        Systematic review of efficacy, pharmacokinetics, and administration of intraventricular vancomycin in adults.
        Neurocrit Care. 2014; 20: 158-171
        • Tängdén T.
        • Enblad P.
        • Ullberg M.
        • Sjölin J.
        Neurosurgical Gram-negative bacillary ventriculitis and meningitis; a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases.
        Clin Infect Dis. 2011; 52: 1310-1316
        • Guardado A.R.
        • Blanco A.
        • Asensi V.
        • et al.
        Multi-drug resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments.
        J Antimicrob Chemo. 2008; 61: 908-913
        • Falgas M.E.
        • Bliziotis I.A.
        • Tam V.H.
        Intraventricular or intrathecal use of polymixins in patients with Gram-negative meningitis: a systematic review of the available evidence.
        Int J Antimicrob Agents. 2007; 29: 9-25
        • Falagas M.E.
        • Giannopoulou K.P.
        • Kokolakis G.N.
        • Rafailidis P.I.
        Fosfomycin; use beyond urinary tract and gastrointestinal infections.
        Clin Infect Dis. 2008; 46: 1069-1077
        • Pfausler B.
        • Spiss H.
        • Dittrich P.
        • Zeitlinger M.
        • Schmutzhard E.
        • Joukhadar C.
        Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis.
        J Antimicrob Chemother. 2004; 53: 848-852